STAT
AUGUST 23, 2024
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
pharmaphorum
AUGUST 23, 2024
Discover how patient organizations play a key role in enabling drug development with the support of EFPIA. Learn more about their involvement and impact in the pharmaceutical industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 23, 2024
High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after STAT reported the company was in dire straits, with one source saying that it planned to wind down operations and seek a buyer by Nov. 1 after the company struggled to raise money or find a partner.
The Pharmacist
AUGUST 23, 2024
Pharmacy leaders have urged the government to engage with pharmacy teams, as it appears to be reviewing its work to tackle major conditions. Earlier this month, public health minister Andrew Gwynne confirmed that work the government's major conditions strategy had been paused, saying: 'As we develop our plans to rebuild the NHS, we will consider […] The post Engage with pharmacy teams on major conditions, leaders urge government appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
AUGUST 23, 2024
The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or quality of care. Whether AI is monitored at all is entirely up to individual health systems. “Everybody is doing this differently, and many health systems are not doing it,” said Mike Pencina, chief data scientist at Duke Health.
Express Pharma
AUGUST 23, 2024
Lupin announced that it has received approval from Health Canada for its biosimilar Pegfilgrastim. This product will be marketed under the brand name Armlupeg and manufactured at Lupin’s Biotech facility in Pune, India. Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim. Pegfilgrastim prefilled syringes are indicated to decrease the incidence of infection, as manifested by febrile neutropenia in patients with non-myeloid m
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
AUGUST 23, 2024
Sun Pharma has launched Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI). Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India.
STAT
AUGUST 23, 2024
A diagnostics company has agreed to stop selling two questionable blood tests as part of a settlement with a consumer watchdog that accused the firm of using “false and misleading advertising” to promote the products. Not only was EpicGenetics claiming that one of its blood tests could definitively diagnose fibromyalgia, the Center for Science in the Public Interest’s October 2023 lawsuit said; the company had also invented a disease wholesale to justify the use of ano
Express Pharma
AUGUST 23, 2024
Dr Reddy’s Laboratories has set a new Guinness World Record for building the largest brochure mosaic (logo) installation. This installation is part of its glycemic happiness awareness initiative for patients with Type 2 diabetes mellitus. The largest installation that entered the Guinness World Record stands at 162 square metres and consists of feedback from healthcare professionals across India on the ‘Glycemic Happiness Scale’.
STAT
AUGUST 23, 2024
A U.S. government agency said that a planned move by Johnson & Johnson to alter payment methods for some hospitals participating in a controversial drug discount program was “inconsistent” with federal law and requires approval before the company can proceed. The statement by the U.S. Health Resources and Services Administration came in response to a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
AUGUST 23, 2024
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.
STAT
AUGUST 23, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch up on our reading and napping, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot, and the rotation will likely include this , this , this , this and this.
The Pharmacist
AUGUST 23, 2024
High and medium-level supply notifications have been issued for norethisterone, methylphenidate prolonged-release and some naltrexone medications. 'High impact' ADHD med shortage may require paper prescriptions Yesterday (22 August) the Department of Health and Social Care (DHSC) issued a 'high impact' medicine supply notification for methylphenidate prolonged-release tablets.
STAT
AUGUST 23, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
AUGUST 23, 2024
The Ministry of Health and Family Welfare has banned 156 fixed-dose combinations (FDCs) medicines which include commonly used antibiotics, antiallergy medication, painkillers and multivitamins. The decision comes following an expert group appointed by the central government and recommendations by the Drug Technical Advisory Board (DTAB). The gazette notification stated, “The said Expert Committee considered this FDC as irrational.
pharmaphorum
AUGUST 23, 2024
AstraZeneca says rumours that it will relocate a planned vaccines facility from the UK to the US "do not seem to be based on facts"
Pharma Times
AUGUST 23, 2024
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
pharmaphorum
AUGUST 23, 2024
Zenas BioPharma has filed an initial public offering in the US seeking $100m+ for obexelimab, a therapy for rare disease IgG4-RD in phase 3
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
AUGUST 23, 2024
Investing in community pharmacy could improve access to care, pharmacy bodies have said, as the UK ranks second-to-last for easy access to evening and weekend care, in a survey of ten countries conduced by the Commonwealth Fund. In the 2023 survey, 16% of UK participants said they found it ‘very’ or ‘somewhat easy’ to get […] The post Pharmacies could improve UK's poor access to evening and weekend care appeared first on The Pharmacist.
pharmaphorum
AUGUST 23, 2024
Novartis and VC Versant set up a new biotech, Borealis Biosciences, using a similar model to an earlier alliance to create Chinook Therapeutics
Pharmaceutical Technology
AUGUST 23, 2024
The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.
pharmaphorum
AUGUST 23, 2024
Discover how apps and telemedicine are driving growth in the healthcare industry with connected health solutions. Learn about the impact of technology on patient care and access to services.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
AUGUST 23, 2024
DirectSens, an Austrian biosensor developer, has launched its latest innovation, the XpressGT RUO kit, designed for the detection of conditions related to insulin resistance, including gestational diabetes (GDM), endometriosis, and liver disease.
Pharma Times
AUGUST 23, 2024
The conference will be held in Basel, Switzerland from 26-28 August
Outsourcing Pharma
AUGUST 23, 2024
Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission (EC) has approved Balversa (erdafitinib) as a once-daily oral monotherapy for adult patients with unresectable or metastatic urothelial carcinoma (mUC) harboring susceptible FGFR3 genetic alterations.
pharmaphorum
AUGUST 23, 2024
ICER says Geron's new drug Rytelo for myelodysplastic syndromes (MDS) is priced three to four times higher than it should be
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
World Pharma News
AUGUST 23, 2024
Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet. A multinational research team led by University of Utah scientists has identified a component within the venom of a deadly marine cone snail, the geography cone, that mimics a human hormone called somatostatin, which regulates the levels of blood sugar and various hormones in the body.
BioPharma Dive
AUGUST 23, 2024
Armed with clinical-stage data, Zenas BioPharma and Bicara Therapeutics both fit the profile of biotechs that have successfully pulled off IPOs this year.
The Pharmacist
AUGUST 23, 2024
The government's temporary ban on gonadotrophin-releasing hormone analogues has been extended until late November. Initially, the ban on the sale and supply of puberty-suppressing hormones, known as ‘puberty blockers', to under-18s, was in place from 3 June to 3 September 2024. And yesterday (22 August) it was renewed until 26 November 2024, as well as […] The post Puberty blockers ban extended until late November appeared first on The Pharmacist.
BioPharma Dive
AUGUST 23, 2024
Agency advisers will discuss whether use of Keytruda and Opdivo should be limited in gastric cancer. Elsewhere, a buzzy genetic drug startup is exploring “strategic options.
Pharmaceutical Business Review
AUGUST 23, 2024
RAG-18 is claimed to be the first saRNA therapeutic to receive ODD status. DMD and BMD are caused by mutations in the DMD gene. The FDA grants ODD to drugs targeting conditions affecting fewer than 200,000 individuals in the US, providing incentives such as seven-year marketing exclusivity upon market approval and a new drug application (NDA) fee waiver.
Expert insights. Personalized for you.
363 
Let's personalize your content